Cargando…

Calreticulin mediates immune recognition of acute myeloid leukemia cells in vivo

Detalles Bibliográficos
Autores principales:	Chen, Xiufen, Fosco, Dominick, Kline, Douglas E, Kline, Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990971/ http://dx.doi.org/10.1186/2051-1426-1-S1-P148

Ejemplares similares

Calreticulin promotes immunity and type I interferon-dependent survival in mice with acute myeloid leukemia
por: Chen, Xiufen, et al.
Publicado: (2017)

CD8α+ dendritic cells dictate immune responses against murine AML
por: Kline, Douglas E, et al.
Publicado: (2013)

Activation of the STING pathway enhances immunity and improves survival in a murine myeloid leukemia model
por: Curran, Emily, et al.
Publicado: (2014)

Peripheral T-cell tolerance in hosts with acute myeloid leukemia
por: Chen, Xiufen, et al.
Publicado: (2013)

Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients
por: Truxova, Iva, et al.
Publicado: (2020)

Calreticulin arms NK cells against leukemia
por: Fucikova, Jitka, et al.
Publicado: (2019)

Targeting the Innate Immune System as Immunotherapy for Acute Myeloid Leukemia
por: Curran, Emily, et al.
Publicado: (2015)

Immune evasion in acute myeloid leukemia: current concepts and future directions
por: Teague, Ryan M, et al.
Publicado: (2013)

Prognostically relevant natural killer cell-mediated immunoediting in acute myeloid leukemia
por: Chan, Christopher J, et al.
Publicado: (2013)

Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapy
por: Johnson, Daniel T., et al.
Publicado: (2021)

Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
por: Fast, Loren, et al.
Publicado: (2013)

Next-generation dendritic cells for immunotherapy of acute myeloid leukemia
por: Schnorfeil, Frauke, et al.
Publicado: (2014)

Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
por: Wemeau, M, et al.
Publicado: (2010)

Metformin suppresses pediatric acute myeloid leukemia cell viability and clonogenicity
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2014)

Sunitinib effectively reduces clonogenic acute myeloid leukemia cells in vitro
por: Ahmed, Farid, et al.
Publicado: (2014)

Growth after hematopoietic stem cell transplantation in children with acute myeloid leukemia
por: Chung, Seung Joon, et al.
Publicado: (2013)

Divergent fates of antigen-specific CD8(+) T cell clones in mice with acute leukemia
por: Chen, Xiufen, et al.
Publicado: (2021)

Severe cutaneous fusariosis in a patient with refractory acute myeloid leukemia
por: Chen, Benjamin C., et al.
Publicado: (2023)

Cell-selective oligonucleotide STAT3 inhibitor for immunotherapy of human acute myeloid leukemia
por: Zhang, Qifang, et al.
Publicado: (2015)

A Phase I trial of MGD006 in patients with relapsed acute myeloid leukemia (AML)
por: Uy, Geoffrey, et al.
Publicado: (2014)

A single nucleotide polymorphism in Wilms’ tumor 1 gene and the risk of acute myeloid leukemia in Sudan
por: Ahmed, Amr A, et al.
Publicado: (2014)

Recombinant trail: a synergistic effect in myeloid leukemias
por: Carvalho, Filipa, et al.
Publicado: (2010)

Frequency and significance of post-intubation hypotension during emergency airway management
por: Heffner, A, et al.
Publicado: (2011)

P430: COMBINATORIAL ADAPTOR-MEDIATED TARGETING OF ACUTE MYELOID LEUKEMIA WITH CAR T-CELLS
por: Volta, Laura, et al.
Publicado: (2023)

Effect of glucose–insulin–potassium infusion on mortality in critically ill patients: a systematic review and meta-analysis
por: Puskarich, M, et al.
Publicado: (2009)

The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia
por: Wang, Jingyi, et al.
Publicado: (2016)

P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors
por: Fey, G, et al.
Publicado: (2014)

Whole blood lactate kinetics in patients undergoing quantitative resuscitation for septic shock
por: Puskarich, MA, et al.
Publicado: (2011)

P591: EXPRESSION PATTERNS AND CLINICAL RELEVANCE OF IMMUNE CHECKPOINT RECEPTORS AND LIGANDS IN ACUTE MYELOID LEUKEMIA
por: Jagurinoski, Milan, et al.
Publicado: (2023)

Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia
por: Schardt, Julian A, et al.
Publicado: (2010)

Agonistic CD40 antibody induces immune-mediated liver damage and modulates tumor-induced myeloid suppressive cells
por: Medina-Echeverz, Jose, et al.
Publicado: (2014)

P424: LANDSCAPE OF CHROMATIN ACCESSIBILITY IN ACUTE MYELOID LEUKEMIA
por: Ochi, Yotaro, et al.
Publicado: (2023)

P016 Effects of Aerobic Exercise versus Inspiratory Muscle training on Apnea-Hypopnea Index in patients with Obstructive Sleep Apnea
por: Ittinirundorn, S, et al.
Publicado: (2023)

Indoleamine 2,3-dioxygenase-1 (IDO1) expression by childhood acute myeloid leukemias inhibits T-cell production of IFN-γ and confers an unfavorable prognosis
por: Rutella, Sergio, et al.
Publicado: (2013)

Immune mediated therapy and MEK inhibition: preclinical assessment of immunobiology and combination activity in vitro and in vivo
por: Stewart, Ross, et al.
Publicado: (2014)

Transient regulatory T-cell (Treg) depletion with IL-2 diphtheria toxin fusion protein enhances clearance of acute myeloid leukemia by haploidentical natural killer (NK) cells
por: Bachanova, Veronika, et al.
Publicado: (2013)

Developmental changes of the response of in vivo ventilation to acute and chronic hypercapnia in rats
por: Dean, JB, et al.
Publicado: (2001)

P20. Lack of T cell exhaustion in acute myeloid leukaemia
por: Schnorfeil, FM, et al.
Publicado: (2014)

Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study
por: de Gruijl, Tanja, et al.
Publicado: (2013)

Molecular recognition of acute myeloid leukemia using aptamers
por: Sefah, Kwame, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_hoes0p9ff6dupca9fmcsi8e451